Influenza

US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally

FDA Clears Cidara Therapeutics' Phase 1 Trial For Immunotherapeutic Antiviral For Influenza

Moderna Posts Data From Early mRNA Flu Vaccine Study, Pivotal Trial On Its Way

FDA Clears Cidara Therapeutics' Phase 1 Trial For Immunotherapeutic Antiviral For Influenza

Moderna Posts Data From Early mRNA Flu Vaccine Study, Pivotal Trial On Its Way

SAB Biotherapeutics' Influenza Candidate Achieves Primary Goal In Mid-Stage Study

US Government Exercises Option To Buy Additional Doses Of BioCryst's Flu Med

SAB Biotherapeutics' Influenza Candidate Achieves Primary Goal In Mid-Stage Study

|

US Government Exercises Option To Buy Additional Doses Of BioCryst's Flu Med

|

Medigus-Backed Polyrizon Develops Technology Potentially Effective Against Influenza Virus

|

Sanofi, Translate Bio Initiate Early-Stage mRNA Influenza Vaccine Trial

|

Influenza Recent News

Why Novavax Shares Down, Despite Positive Results from Flu/COVID-19 Vaccine Testing

Novavax, Inc. (NVAX) announced positive results from the animal study of its combo vaccine for influenza and COVID-19. The positive news however did little to stem the sell-off in shares that began in late April.

|

Cidara Therapeutics Stock Rises After Collaboration Agreement Janssen For Influenza Candidates

|

BioCryst Gains After FDA Nod For Expanded Use of RAPIVAB

|

CDC: 44 States Still Reporting High Flu Activity

|

Altimmune's Flu Shot Study: What You Need To Know

|

Altimmune Shares Volatile After Presentation of Positive Flu Vaccine Data at IDWeek

|

Near-Term Catalysts, Long-Term Opportunities Make Quidel A Strong Buy, Says Raymond James

|

CDC Still Recommends Sanofi, GlaxoSmithKline Vaccines As Flu-Related Deaths Rise

|

Analyst: When Americans Sneeze, Teladoc And Athenahealth Profit

|

Don't Bother Using FluMist; It Just Doesn't Work

|